EVENTS

2025/09/05
患者がん移植ゼブラフィッシュモデル(PDXZ)の新しい展開

2025/06/16
患者がん移植ゼブラフィッシュモデル(PDXZ)のFDA受け入れ

2025/04/15
Novel Fluorescent Dye ZMB741 for Podocytopathy Drug Screening

2025/04/10
In Vivo Assessment of Individual and Total Proteinuria in Zebrafish Larvae Using the Solvatochromic Compound ZMB741

2025/02/01
Zebrafish-Based Oncocardionephrologyの新しい展開

一覧へ

》Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening

2021/10/13

BioJapan2021: Oct 13-15, 2021
We developed novel zebrafish model for patient-derived xenograft (PDXZ), and demonstrated that PDXZ has high rate and speed of engraftment in normal zebrafish when the immune system is immature, requires less than 100 cancer cells for transplantation, and can be quantitatively analyzed in 2 days. We report on drug efficacy screening system that can be quantitatively analyzed within a week.

EVENTS

》Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening

関連リンク

関連ファイル